Acer Therapeutics Receives Complete Response Letter from U.S. FDA for use of EDSIVO(TM) (celiprolol) in vEDS Patients

Stock Information for Acer Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.